EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Molecular Hydrogen as an Adjuvant Therapy in Severe Lupus Serositis With Heart Failure: A Case Report on Immune Modulation and Fatigue Reduction

Yun-Ting Lin, Jeng-Wei Lu, Yi-Jung Ho, Shan-Wen Lui, Ting-Yu Hsieh, Hsiao-Chen Liu, Kuang-Yih Wang, Feng-Cheng Liu

In Vivo · 2025

DOI: 10.21873/invivo.13924 ↗

Kurz gefasst

Fallbericht in der Zeitschrift In Vivo, 2025. Verfasst von Yun-Ting Lin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, R.O.C. Hauptthemen laut MEDLINE: Heart Failure, Lupus Erythematosus, Systemic, Hydrogen, Fatigue. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND/AIM: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by multi-organ inflammation and damage across multiple organs, typically managed with steroids and immunomodulators. However, prolonged use of these treatments is often associated with significant side effects, underscoring the need for adjunctive therapies that improve disease outcomes while minimizing adverse effects. Molecular hydrogen (H2) has demonstrated potential as an antioxidant and anti-inflammatory agent. This report discusses a case of SLE with cardiac complications, evaluating the therapeutic impact of molecular hydrogen therapy on fatigue, immune modulation, and cardiac function. CASE REPORT: A 51-year-old female with SLE and acute decompensated heart failure initially received steroids and immunomodulators for disease management. Subsequently, molecular hydrogen therapy was introduced as an adjuvant treatment. Over several months, her cardiac function showed notable improvement, evidenced by reductions in anti-dsDNA and anti-Ro52 antibody levels, and Pro-BNP levels, as well as favorable shifts in T and B cell subsets. Additionally, the patient experienced a significant reduction in fatigue. She successfully tapered off steroids while maintaining disease stability with ongoing molecular hydrogen therapy. CONCLUSION: This case highlights the potential of molecular hydrogen therapy as an adjuvant treatment in SLE, with observed benefits in immune modulation and fatigue reduction. Further studies are warranted to elucidate its therapeutic role and applicability in autoimmune diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureLupus Erythematosus, SystemicHydrogenFatigueSerositisHumansFemaleMiddle AgedTreatment OutcomeImmunomodulation

Stichwörter der Autor:innen

Systemic lupus erythematosuscardiac functionfatigue reductionimmune modulationmolecular hydrogen

Substanzen

Hydrogen

Autor:innen und Institutionen

  • Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, R.O.C.
  • Biotech Research and Innovation Centre, University of Copenhagen, Copenhagen, Denmark.
  • The Finsen Laboratory, Rigshospitalet/National University Hospital, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • School of Pharmacy, National Defense Medical Center, Taipei, Taiwan, R.O.C.
  • Graduate Institute of Life Sciences, National Defense Medical Center, Taipei, Taiwan, R.O.C.
  • Department of Internal Medicine, Linkou Chang-Gung Memorial Hospital, Taoyuan, Taiwan, R.O.C.

Zitieren

APA

Lin, Y. T., Lu, J. W., Ho, Y. J., Lui, S. W., Hsieh, T. Y., Liu, H. C., Wang, K. Y., & Liu, F. C. (2025). Molecular Hydrogen as an Adjuvant Therapy in Severe Lupus Serositis With Heart Failure: A Case Report on Immune Modulation and Fatigue Reduction. In Vivo. https://doi.org/10.21873/invivo.13924

Vancouver

Lin YT, Lu JW, Ho YJ, Lui SW, Hsieh TY, Liu HC, et al. Molecular Hydrogen as an Adjuvant Therapy in Severe Lupus Serositis With Heart Failure: A Case Report on Immune Modulation and Fatigue Reduction. In Vivo. 2025. doi:10.21873/invivo.13924

BibTeX
@article{Lin2025,
  author = {Lin, Yun-Ting and Lu, Jeng-Wei and Ho, Yi-Jung and Lui, Shan-Wen and Hsieh, Ting-Yu and Liu, Hsiao-Chen and Wang, Kuang-Yih and Liu, Feng-Cheng},
  title = {Molecular Hydrogen as an Adjuvant Therapy in Severe Lupus Serositis With Heart Failure: A Case Report on Immune Modulation and Fatigue Reduction},
  journal = {In Vivo},
  year = {2025},
  doi = {10.21873/invivo.13924}
}
Kostenlos starten →